SCHEMBL30199797

SCHEMBL30199797

CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCNCC4)ccc3OCC)nc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 18/20 1.00
PDE3B Q13370 3/20 0.86
PDE3A Q14432 3/20 0.86
ABCC4 O15439 2/20 0.86
PDE2A O00408 1/20 0.86
ABCC5 O15440 1/20 0.86
PDE6D O43924 1/20 0.86
PDE8A O60658 1/20 0.86
PDE9A O76083 1/20 0.86
ABCB11 O95342 1/20 0.86
CYP3A4 P08684 1/20 0.86
HTR1A P08908 1/20 0.86
PDE6A P16499 1/20 0.86
PDE6G P18545 1/20 0.86
PDE4A P27815 1/20 0.86
ADORA2A P29274 1/20 0.86
ADORA1 P30542 1/20 0.86
ADRA1A P35348 1/20 0.86
PDE6B P35913 1/20 0.86
PDE6C P51160 1/20 0.86

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1141 1.00 PDE5A (1.00) PDE5APDE3BPDE3AABCC4PDE2A
SCHEMBL14836841 0.97 PDE5A (0.94) PDE5APDE3BPDE3AABCC4PDE2A
SCHEMBL30848678 0.95 PDE5A (0.95) PDE5APDE3BPDE3AABCC4PDE2A
SCHEMBL997 0.94 PDE5A (0.89) PDE5APDE3BPDE3AABCC4PDE2A
SCHEMBL24430033 0.94 PDE5A (0.89) PDE5APDE3BPDE3AABCC4PDE2A
SCHEMBL25118239 0.94 PDE5A (0.88) PDE5APDE3BPDE3AABCC4PDE2A
SCHEMBL28415489 0.93 PDE5A (0.88) PDE5APDE3BPDE3AABCC4PDE2A
Sildenafil SCHEMBL5683880 0.93 PDE5A (1.00) PDE5APDE3BPDE3AABCC4PDE2A
Sildenafil SCHEMBL1895 0.93 PDE5A (1.00) PDE5APDE3BPDE3AABCC4PDE2A
Sildenafil SCHEMBL29361663 0.93 PDE5A (1.00) PDE5APDE3BPDE3AABCC4PDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120025295-A Difluoromethyl and amino substituted olefin compound and synthesis method thereof 浙江师范大学 2025-05-23 CN disclosed
CN-117890459-B Quick screening method for illegally adding chemical drugs into foods based on MSRIT-MS/MS 南京市食品药品监督检验院 2024-10-18 CN disclosed
US-20230348470-A1 GUT-TARGETED PHOSPHODIESTERASE INHIBITORS AUGUSTA UNIVERSITY RESEARCH INSTITUTE, INC. (US) 2023-11-02 US disclosed
CN-115598338-A Colloidal gold test strip for detecting PDE-5 inhibitor and preparation method and application thereof 广东省药品检验所(广东省药品质量研究所、广东省口岸药品检验所)(CN) 2023-01-13 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348470-A1 GUT-TARGETED PHOSPHODIESTERASE INHIBITORS PDE5A, PDE2A, PDE12 PDE5A 1/4885PDE3B 6/4885PDE3A 4/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.